Eosinophilic lung diseases

Ulrich Costabel (Germany)

Source: ERS Course 2019 - Summer school of adult respiratory medicine

Number: 20

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ulrich Costabel (Germany). Eosinophilic lung diseases. ERS Course 2019 - Summer school of adult respiratory medicine

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Rare interstitial lung diseases II: Eosinophilic pneumonias Source: ERS Courses: Interstitial Lung Diseases Year: 2019
Eosinophilic COPD Source: Eur Respir Monogr 2022; 95: 100-118 Year: 2022
Eosinophilic asthma Source: Eur Respir Monogr 2022; 95: 73-99 Year: 2022
Eosinophilic inflammation and asthma control Source: Annual Congress 2009 - Inflammation and airways Year: 2009
Interstitial lung diseases Source: Eur Respir Monogr 2015; 70: 99-115 Year: 2015
Interstitial lung diseases Source: Annual Congress 2012 - MS4 Interpreting high-resolution computed tomography scans: top tips Year: 2012
Interstitial lung diseases Source: Annual Congress 2013 –Ceremony for ERS Research Award on Idiopathic Pulmonary Fibrosis (financially supported by InterMune) followed by Clinical Year in Review I Year: 2013
Interstitial lung diseases Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019 Year: 2019
Interstitial lung diseases Source: Eur Respir Monogr 2014; 65: 79-87 Year: 2014
Interstitial lung diseases Source: ERS Course 2018 - Summer school of paediatric respiratory medicine Year: 2018
Interstitial lung diseases Source: HERMES Summer School 2014 - Educational material Year: 2014
Interstitial lung diseases Source: ERS Course 2015 Year: 2015
Eosinophilic pneumonias Source: Eur Respir Monogr 2022; 95: 141-152 Year: 2022
Rare interstitial lung diseases Source: School Course 2014 - Interstitial lung diseases Year: 2014
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019 Year: 2019
Eosinophilic refractory inflammation in OCS-dependent severe asthma Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
Interstitial lung diseases misdiagnosed as tuberculosis. Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017